Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.
Gameto has raised $44.0M in total funding. The most recent round was Series C. The last funding was announced in August 2025.
Gameto's investors include Pontiva Healthcare Partners, Insight Partners, Gaingels, RA Capital Management, Two Sigma Ventures.
Gameto is headquartered in New York, United States.
Gameto is a biotechnology company developing therapeutics of the female reproductive system using cell engineering.
Gameto is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Gameto — Funding & Investors." VCBacked, August 12, 2025, https://www.vcbacked.co/company/gameto. Accessed July 19, 2026.
VCBacked. (2025). Gameto — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/gameto
{{cite web |title=Gameto — Funding & Investors |url=https://www.vcbacked.co/company/gameto |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated